Reference
Inci M, et al. Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: case report. Acta Neurologica Belgica 122: 1389-1391, No. 5, Oct 2022. Available from: URL: http://doi.org/10.1007/s13760-022-01953-w
Rights and permissions
About this article
Cite this article
Alemtuzumab/natalizumab. Reactions Weekly 1949, 29 (2023). https://doi.org/10.1007/s40278-023-36009-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-36009-8